The Global Fund to Fight AIDS, Tuberculosis and Malaria (the “Global Fund”) is seeking proposals from regional stakeholders to implement a multicountry program under the Catalytic Investments for the 2017-2019 Allocation Period. Of the US$ 65,000,000 made available for this strategic priority area, this RFP refers to the US$ 7,500,000 made available under Multicountry priority area “Tuberculosis: Interventions among refugees in Eastern Africa”. The multi-country proposal will focus on the refugee population in the horn of Africa countries. The last date of submission of application is April 30, 2018.
Applicants will be notified of the outcomes of the review by the Global Fund Secretariat and Technical Review Panel (TRP). The successful applicant or applicants will then, with the proposed implementing entity and the support of the Global Fund Secretariat, proceed to grant-making. The maximum duration of each grant shall be three years from the grant implementation start date. The grant is expected to start on 1st January 2019. Proposal will be considered from a single organization or from a consortium,4 who provided the proposal that demonstrates sufficient technical capacity and strategic initiative to fulfill the terms.
Eligibility Requirement:
- An Applicant must be a Regional Coordinating Mechanism (RCM) or Regional Organization (RO)5 that demonstrates technical and programmatic capacity in the multicountry strategic priority, sufficient regional knowledge and experience in broad stakeholders engagement, and a commitment to open and inclusive dialog and decision-making.
- Applicants must develop and demonstrate an inclusive and evidence-informed regional
dialogue. - It must be based on relevant national disease plans and regional strategies. A regional dialogue should actively engage representatives from all stakeholder groups involved in the response to the diseases, including those involved in building resilient and sustainable systems for health, and must include key and vulnerable populations disproportionately impacted by the diseases.
The grant will have a catalytic effect in strengthening:
- Collaboration, information sharing and improve TB ,MDR-TB and TB/HIV diagnosis/treatment and referrals between refugee settlements and National Tuberculosis Programs (NTPs)/National AIDS Programs (NAPs) in the host countries,
- Foster cross-border collaboration, information sharing and referrals among NTPs/NAPs in the selected countries in the region,
- Advocate for more resources and supports for TB, MDR-TB and TB/HIV including from domestic and other sources.
- The grant will ensure continued and quality assured services delivered to refugees
through the national programs in host countries but will not directly provide services
such as diagnosis and treatment.
The target population of this multicountry grant is refugees in and from horn of Africa countries with a focus on gaps related to capacity and coordination needed for diagnosis and treatment of TB and MDR-TB. The refugee populations affected in East African countries including Djibouti, Eritrea, Ethiopia, Kenya, Somalia, South Sudan, Sudan and Uganda.
There is still high burden of tuberculosis, including drug-resistant TB and TB/HIV in East African countries. The incidence rate of TB for all age groups (including HIV) per 100,000 populations in Djibouti (335), Eritrea (74), Ethiopia (177), Kenya (348), Somalia (270), Sudan (82), South Sudan (146) and Uganda (201) are yet very high (Global TB report 2017). The incidence rate of MDR/RR-TB per 100,000 populations are also significantly high: in Djibouti (18), Eritrea (2.9), Ethiopia (5.7), Kenya (6.2), Somalia (27), Sudan (3.1), South Sudan (5.4) and Uganda (4.7) and Ethiopia, Kenya and Somali are part of MDR-TB high-burden countries.
The objective of multicountry grants is to target a limited number of key, strategic multicountry priorities deemed critical to meet the aims of the 2017-2022 Global Fund Strategy and not able to be addressed through country allocations alone. Funding proposal for multicountry catalytic funding should focus on regional and cross-border collaboration, as well as complementary with national disease programs, in order to achieve maximum catalytic impact in the strategic priority area.
For further information on Eligibility and Application Process, please visit: The Global Fund